IPEX as a Result of Mutations in FOXP3

Por van der Vliet, Hans J. J., Nieuwenhuis, Edward E.
Publicado em 2007

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

Por King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado no Front Immunol (2018)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

Por King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado no Front Immunol (2018)

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

Por Stolk, Dorian, van der Vliet, Hans J., de Gruijl, Tanja D., van Kooyk, Yvette, Exley, Mark A.
Publicado no Front Immunol (2018)

Hepatitis C Virus (HCV)-Specific CD8(+) Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

Por Alatrakchi, Nadia, Graham, Camilla S., van der Vliet, Hans J. J., Sherman, Kenneth E., Exley, Mark A., Koziel, Margaret James
Publicado em 2007

Circulating Myeloid Dendritic Cells of Advanced Cancer Patients Result in Reduced Activation and a Biased Cytokine Profile in Invariant NKT Cells

Por van der Vliet, Hans J. J., Wang, Ruojie, Yue, Simon C., Koon, Henry B., Balk, Steven P., Exley, Mark A.
Publicado em 2008

Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma

Por HADJ, JAMAL OULAD, BRAVEN, ROGIER DEN, TILLIER, CORRINE, SCHRIJVER, HANS M., VERHEUL, HENK M.W., VAN DER VLIET, HANS J.
Publicado em 2012

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

Por Veluchamy, John P., Kok, Nina, van der Vliet, Hans J., Verheul, Henk M. W., de Gruijl, Tanja D., Spanholtz, Jan
Publicado no Front Immunol (2017)

Irinotecan-Induced Dysarthria

Por Dressel, Albertine J., van der Mijn, Johannes C., Aalders, IJke J., Rinkel, Rico N.P.M., van der Vliet, Hans J.
Publicado em 2012

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy

Por Werter, Inge M., Schneiders, Famke L., Scotet, Emmanuel, Verheul, Henk M.W., de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado no Oncoimmunology (2014)

Immunological effects of everolimus in patients with metastatic renal cell cancer

Por Huijts, Charlotte M, Santegoets, Saskia J, de Jong, Tamarah D, Verheul, Henk M, de Gruijl, Tanja D, van der Vliet, Hans J
Publicado no Int J Immunopathol Pharmacol (2017)

Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Por Kim, Jong Yeob, Kronbichler, Andreas, Eisenhut, Michael, Hong, Sung Hwi, van der Vliet, Hans J., Kang, Jeonghyun, Shin, Jae Il, Gamerith, Gabriele
Publicado no Cancers (Basel) (2019)

Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials

Por Kim, Jong Yeob, Lee, Keum Hwa, Eisenhut, Michael, van der Vliet, Hans J., Kronbichler, Andreas, Jeong, Gwang Hun, Shin, Jae Il, Gamerith, Gabriele
Publicado no Cancers (Basel) (2019)

Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis

Por Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Shin, Jae Il, Gamerith, Gabriele
Publicado no J Clin Med (2020)

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies

Por Goedegebuure, Ruben S.A., Wentink, Madelon Q., van der Vliet, Hans J., Timmerman, Peter, Griffioen, Arjan W., de Gruijl, Tanja D., Verheul, Henk M.W.
Publicado no Oncologist (2020)

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function

Por Veluchamy, John P., Delso-Vallejo, María, Kok, Nina, Bohme, Fenna, Seggewiss-Bernhardt, Ruth, van der Vliet, Hans J., de Gruijl, Tanja D., Huppert, Volker, Spanholtz, Jan
Publicado no Sci Rep (2017)

Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis

Por Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Hong, Sung Hwi, Shin, Jae Il, Gamerith, Gabriele
Publicado no J Clin Med (2019)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

Por Veluchamy, John Pradeep, Spanholtz, Jan, Tordoir, Marleen, Thijssen, Victor L., Heideman, Daniëlle A. M., Verheul, Henk M. W., de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado no PLoS One (2016)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

Por Huijts, Charlotte M, Santegoets, Saskia J, van den Eertwegh, Alfons J, Pijpers, Laura S, Haanen, John B, de Gruijl, Tanja D, Verheul, Henk M, van der Vliet, Hans J
Publicado em 2011

Ex vivo Analysis of Resident Hepatic Pro-inflammatory CD1d-reactive T cells & Hepatocyte Surface CD1d Expression in Hepatitis C

Por Yanagisawa, Kazuhiko, Yue, Simon, van der Vliet, Hans J., Wang, RuoJie, Alatrakchi, Nadia, Golden-Mason, Lucy, Schuppan, Detlef, Koziel, Margaret J., Rosen, Hugo R., Exley, Mark A.
Publicado em 2013